Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation.
Kordelas L, Verheyen J, Beelen DW, Horn PA, Heinold A, Kaiser R, Trenschel R, Schadendorf D, Dittmer U, Esser S; Essen HIV AlloSCT Group. Kordelas L, et al. Among authors: verheyen j. N Engl J Med. 2014 Aug 28;371(9):880-2. doi: 10.1056/NEJMc1405805. N Engl J Med. 2014. PMID: 25162903 No abstract available.
Reduced Frequencies and Activation of Regulatory T Cells After the Treatment of HIV-1-Infected Individuals with the CCR5 Antagonist Maraviroc Are Associated with a Reduction in Viral Loads Rather Than a Direct Effect of the Drug on Regulatory T Cells.
Joedicke JJ, Dirks M, Esser S, Verheyen J, Dittmer U. Joedicke JJ, et al. Among authors: verheyen j. Viral Immunol. 2016 Apr;29(3):192-6. doi: 10.1089/vim.2015.0046. Epub 2016 Jan 26. Viral Immunol. 2016. PMID: 27035639
Pre-exposure prophylaxis failure with tenofovir disoproxil.
Streeck H, Verheyen J, Storim J, Dittmer U, Jochum C, Timm J, Esser S. Streeck H, et al. Among authors: verheyen j. AIDS. 2017 Jan 2;31(1):176-177. doi: 10.1097/QAD.0000000000001280. AIDS. 2017. PMID: 27898596 No abstract available.
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia.
Widera M, Dirks M, Bleekmann B, Jablonka R, Däumer M, Walter H, Ehret R, Verheyen J, Esser S. Widera M, et al. Among authors: verheyen j. Med Microbiol Immunol. 2017 Jun;206(3):203-215. doi: 10.1007/s00430-017-0494-1. Epub 2017 Feb 20. Med Microbiol Immunol. 2017. PMID: 28220254 Free PMC article.
Antiretroviral therapy suppresses rectal HIV-RNA shedding despite inflammation in MSM with rectal C. trachomatis and N. gonorrhoeae infections-a cross-sectional, single-center study.
Storim J, Verheyen J, Wolff E, Wohlschlaeger J, Heintschel von Heinegg E, Schadendorf D, Esser S. Storim J, et al. Among authors: verheyen j. Sex Transm Infect. 2019 Mar;95(2):95-98. doi: 10.1136/sextrans-2017-053409. Epub 2018 Feb 3. Sex Transm Infect. 2019. PMID: 29431149 Clinical Trial.
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.
Colagrossi L, Hermans LE, Salpini R, Di Carlo D, Pas SD, Alvarez M, Ben-Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Lepej SZ, Weis N, Yalcinkaya T, Boucher CAB, Wensing AMJ, Perno CF, Svicher V; HEPVIR working group of the European Society for translational antiviral research (ESAR). Colagrossi L, et al. Among authors: verheyen j. BMC Infect Dis. 2018 Jun 1;18(1):251. doi: 10.1186/s12879-018-3161-2. BMC Infect Dis. 2018. PMID: 29859062 Free PMC article.
126 results